Weight Bearing Over-ground Stepping in an Exoskeleton with Non-invasive Spinal Cord Neuromodulation after Motor Complete Paraplegia.
Parag Gad, Yury Gerasimenko, Sharon Zdunowski...
https://pubmed.ncbi.nlm.nih.gov/28642680Actively Recruiting
Led by Xuanwu Hospital, Beijing · Updated on 2025-05-20
3
Participants Needed
1
Research Sites
52 weeks
Total Duration
X
Xuanwu Hospital, Beijing
Lead Sponsor
B
Beijing Xinzhida Neural Technology Co., Ltd
Collaborating Sponsor
Researchers are evaluating the safety and technical feasibility of a new brain-machine interface (BCI)-assisted spinal cord stimulation (SCS) combined with an exoskeleton (EXS) system in adults aged 14 to 65 with chronic spinal cord injury (SCI). This study aims to determine if this system can safely and effectively improve lower limb motor function and quality of life in people who have had SCI for at least six months and have certain levels of motor impairment. Participants will receive implanted devices including high-density ECoG electrodes over the motor cortex and spinal cord stimulation electrodes at T11-L2. The system will be calibrated to synchronize the brain signals decoded by the BCI with the spinal cord stimulation and exoskeleton-assisted gait training. After implantation and calibration phases, participants will engage in daily one-hour training sessions, five times per week for one year, with ongoing adjustments to the system based on performance. Safety and efficacy will be assessed at multiple time points up to 12 months post-implantation. During the study, participants will be monitored through various assessments including motor function tests, neurophysiological measures, quality of life surveys, and device performance checks. Researchers will track adverse events and technical device data to evaluate safety. Follow-up visits will occur at 1, 2, 3, 6, and 12 months after device implantation. The study includes remote monitoring for device function and emergency support if needed, with a total participation time of at least one year.
CONDITIONS
BCI-Assisted SCS-EXS for Gait Optimization
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial implantation and calibration period
Participants undergo implantation of BCI electrodes over the motor cortex and spinal cord stimulation (SCS) electrodes, followed by system calibration to synchronize brain signals and spinal stimulation for gait assistance.
1 to 2 visits (in-person) for implantation and calibration
Duration - Daily sessions, 60 minutes each, 5 times per week for 1 year
Participants engage in daily rehabilitation training sessions combining brain-controlled spinal cord stimulation and exoskeleton-assisted gait training to promote neuroplasticity and functional recovery.
5 training sessions per week for 12 months
Duration - 12 months post-intervention
Participants attend safety and efficacy assessments at multiple time points after the intervention to monitor progress and device function.
Visits at 1, 2, 3, 6, and 12 months post-implantation
Total: 1 location
1
Xuanwu Hospital ,Capital Medical University
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
P
Penghao Liu, Doctor
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Parag Gad, Yury Gerasimenko, Sharon Zdunowski...
https://pubmed.ncbi.nlm.nih.gov/28642680Ashraf S Gorgey, Satinder Gill, Matthew E Holman...
https://pubmed.ncbi.nlm.nih.gov/32023011Andreas Rowald, Salif Komi, Robin Demesmaeker...
https://pubmed.ncbi.nlm.nih.gov/35132264Henri Lorach, Andrea Galvez, Valeria Spagnolo...
https://pubmed.ncbi.nlm.nih.gov/37225984Penghao Liu, Yuanchen Cheng, Zhuofan Xu...
https://pubmed.ncbi.nlm.nih.gov/39675019